Solventum

Solventum is building a new manufacturing facility in Jarinu, São Paulo, Brazil, with an investment of hundreds of millions of reais. The plant is expected to be fully operational in 2027.

Solventum opened a $220 million expansion of its Brookings, South Dakota facility, adding 275,000 square feet of lab and warehouse space and 16 new shipping docks, bringing the total facility to one million square feet. The plant produces IV site securements, surgical drapes, and tapes.

Solventum announced a definitive agreement to acquire Acera Surgical for $725 million in cash plus up to $125 million in contingent payments, expanding into synthetic tissue matrices.

Thermo Fisher Scientific entered a definitive agreement to acquire Solventum's Purification & Filtration business for approximately $4.1 billion in cash. The business generated about $1 billion in revenue in 2024 and has around 2,500 employees globally.

Solventum (formerly 3M Health Care) opened a new production line in Wuppertal, Germany, for manufacturing 3M Liqui-Cel membrane contactors. The €40 million investment will triple production capacity by 2025.

Solventum completed a EUR 33 million modernization of its medical device production site in Kamen, North Rhine-Westphalia, renewing building infrastructure and increasing production capacity. The site is Solventum's largest outside the USA and produces nonwoven materials for tapes, bandages, and dressings.